Business Context and Reporting Period
This Form 6-K filing by Smith & Nephew plc is a regulatory notification dated July 4, 2024. The document serves as a "Notification of Major Holdings" submitted to the UK Financial Conduct Authority (FCA) and the issuer, disclosing a change in share ownership by an institutional investor.
Key Financial Metrics
This filing is a corporate governance disclosure regarding share ownership and does not contain financial performance data. Consequently, there are no reported figures for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The material change disclosed is an acquisition of voting rights by Cevian Capital II GP Limited (acting for Cevian Capital II Master Fund L.P.).
- Threshold Crossed: The investor crossed the 5% voting rights threshold on July 2, 2024.
- Total Voting Rights: The resulting position is 5.021046% of the total voting rights attached to shares.
- Share Count: The position comprises 43,901,527 voting rights.
- Instrument Type: The holding consists entirely of direct voting rights attached to shares (ISIN: GB0009223206). There are no financial instruments (derivatives) contributing to this percentage.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of operational risks. It is a statutory notification of a change in major shareholding.
Ownership Structure: The legal owner of the shares is Aurora Nominees Limited (acting as nominee), holding the shares on behalf of UBS AG (acting as custodian). Cevian Capital II GP Limited is identified as the ultimate controlling person.
Investor Verification Checklist
- Verify the current total share capital of Smith & Nephew plc to confirm the 5.02% stake represents approximately 43.9 million shares.
- Monitor subsequent filings to determine if Cevian Capital intends to increase its stake further or propose strategic changes.
- Confirm the identity of the ultimate beneficial owner (Cevian Capital II Master Fund L.P.) and its historical investment strategy regarding healthcare companies.
- Note that this filing does not reflect the company's operational performance; refer to the latest Form 20-F or interim results for financial metrics.